ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 746701 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 746701; 2) Community: the network communities that were significantly associated with the response to NSC 746701; 3) Molecule: the relationships between components within communities and NSC 746701; 4) MDR: the compounds that were significantly associated with the NSC 746701.

NSC Compound Enrichment Correlation
NSC 180973 Tamoxifen citrate 0.0244632509325736 0.37531523
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0244632509325736 0.30484173
NSC 32937 Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride 0.0244632509325736 0.36795386
NSC 333856 NSC 329083 0.0244632509325736 0.11847054
NSC 382049 2,4-Pyrimidinediamine, 6-ethyl-5-[3-nitro- 4-[(2-phenylethyl)amino]phenyl]- 0.0244632509325736 0.13111258
NSC 46683 Null 0.0244632509325736 0.1565271
NSC 58575 Pyrimidine, 2,4,5-trichloro-6-isopropyl- 0.0244632509325736 0.34243449
NSC 617309 Null 0.0244632509325736 0.40143648
NSC 625154 21-Oxabicyclo[16.2.1]heneicosane-4,9,14,18,20-pentaene, 3,6,8,11,13,16-hexaoxo-2,2,7,7,,12,12,17,17-octamethyl- 0.0244632509325736 0.27294637
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.0244632509325736 0.44313378
Total:63  Current:32    [First] [Prev] [Next] [Last]